VEGF and CD31 Association in Pituitary Adenomas

[1]  C. Leães,et al.  Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  D. Becu-Villalobos,et al.  Invasive Giant Prolactinoma with Loss of Therapeutic Response to Cabergoline: Expression of Angiogenic Markers , 2009, Endocrine pathology.

[3]  Paolo Gaetani,et al.  Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue , 2008, Neurosurgical Review.

[4]  M. Low,et al.  Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. , 2006, Frontiers of hormone research.

[5]  A. Aoki,et al.  Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas , 2006, Journal of Molecular Histology.

[6]  M. Pawlikowski,et al.  Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas , 2005, Pituitary.

[7]  M. Niveiro,et al.  Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. , 2005, Human pathology.

[8]  D. Becu-Villalobos,et al.  Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. , 2005, Endocrinology.

[9]  D. Adams,et al.  Peliosis of the spleen with massive recurrent haemorrhagic ascites, despite splenectomy, and associated with elevated levels of vascular endothelial growth factor. , 2004, European journal of gastroenterology & hepatology.

[10]  F. Yamasaki,et al.  Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. , 2004, Hiroshima journal of medical sciences.

[11]  Adrian L Harris,et al.  Angiogenesis in endocrine tumors. , 2003, Endocrine reviews.

[12]  M. Theodoropoulou,et al.  Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development , 2003, Molecular and Cellular Endocrinology.

[13]  J. Itoh,et al.  Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas , 2003, Microscopy research and technique.

[14]  B. Scheithauer,et al.  Angiogenesis in normal and neoplastic pituitary tissues , 2003, Microscopy research and technique.

[15]  J. Franklyn,et al.  Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. , 2002, The Journal of clinical endocrinology and metabolism.

[16]  E. Uhl,et al.  Vascular Endothelial Growth Factor Production and Regulation in Rodent and Human Pituitary Tumor Cells in vitro , 2001, Neuroendocrinology.

[17]  L. Chin,et al.  Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Scheithauer,et al.  Microvessel density in pituitary adenomas and carcinomas , 2001, Virchows Archiv.

[19]  Y. N. Park,et al.  Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. , 2000, Archives of pathology & laboratory medicine.

[20]  A. Harris,et al.  Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. , 2000, Journal of Endocrinology.

[21]  A. Harris,et al.  Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour , 2000, British Journal of Cancer.

[22]  A. Harris,et al.  Angiogenesis in pituitary adenomas and the normal pituitary gland. , 2000, The Journal of clinical endocrinology and metabolism.

[23]  R Folberg,et al.  Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.

[24]  B. Scheithauer,et al.  Localization of vascular endothelial growth factor in nontumorous human pituitaries , 1999, Endocrine pathology.

[25]  D. Mooney,et al.  Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. , 1999, The American journal of pathology.

[26]  J. Isner,et al.  Age-dependent impairment of angiogenesis. , 1999, Circulation.

[27]  W. Cavenee,et al.  Expression of vascular endothelial growth factor in human brain tumors , 1998, Acta Neuropathologica.

[28]  E. Hedley‐Whyte,et al.  Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. , 1993, Journal of neurosurgery.

[29]  J. Schechter.  Ultrastructural changes in the capillary bed of human pituitary tumors. , 1972, The American journal of pathology.

[30]  B. Scheithauer,et al.  Pituitary Adenoma with Peliosis: A Report of Two Cases , 2009, Endocrine pathology.

[31]  S. Yamada,et al.  Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas , 2004, Endocrine pathology.

[32]  B. Scheithauer,et al.  Microvascular structural entropy: A novel approach to assess angiogenesis in pituitary tumors , 2003, Endocrine pathology.

[33]  M. Gasperi,et al.  Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas , 2003, Journal of endocrinological investigation.

[34]  H. Stępień,et al.  Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. , 2000, Cytobios.

[35]  A. Yamaura,et al.  Proliferation, Vascular Endothelial Growth Factor Expression and Cavernous Sinus Invasion in Growth Hormone Secreting Pituitary Adenomas , 2000, Acta Neurochirurgica.

[36]  B. Scheithauer,et al.  Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas , 1999, Endocrine pathology.

[37]  M. Pawlikowski,et al.  Immunocytochemical investigations on the vascularization of pituitary adenomas , 1997, Endocrine pathology.

[38]  K. Kovacs,et al.  Cushing’s Syndrome from an ectopic pituitary adenoma with peliosis: A histological, immunohistochemical, and ultrastructural study and review of the literature , 1997, Endocrine pathology.

[39]  B. Scheithauer,et al.  Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. , 1996, Neurosurgery.

[40]  B. Scheithauer,et al.  Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study , 1995, Endocrine pathology.